Searching across hundreds of databases

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Topical application of the hematostatic agent Surgiflo® could attenuate brain injury in experimental TBI mice.

D Guo | D Li | J Li | Y Li | X Hu | F Guan | B Yang
Neurological research | 2017 Sep

Pubmed ID: 28566060

TBI Model

  • Weight-drop model
  • Modified Marmarou's Weight-drop model
  • Animal Information

  • Species: mouse
  • Strain: C57BL/6
  • Age (weeks): 10 - 12
  • Weight (grams): 20 - 26
  • Assessments

    Hematoxylin and Eosin, Nissl staining, Serum S100β, Neurological Severity Score (NSS)

    TBI model parameters

  • Impact Depth (mm): No information available
  • Impact Duration (ms): No information available
  • Impact Velocity (m/s): No information available
  • Impactor Tip: No information available
  • Device Name

    No information available

    Associated Datasets

    No information available

    Associated Protocols

    No information available